Affiliations 

  • 1 Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, 20400, Kuala Terengganu, Terengganu, Malaysia
  • 2 Paediatric Department, Hospital Kuala Lumpur (HKL), Jalan Pahang, 50586, Kuala Lumpur, Malaysia
  • 3 Emergency Department, Rockingham Peel Group, South Metropolitan Health Service, 33 Elanora Drive, Rockingham, 6967, PO Box 2033, West Australia, Australia
  • 4 Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi Mara (UiTM), Bandar Puncak Alam, 42300, Selangor, Malaysia
  • 5 School of Medical Science, Health Campus, Universiti Sains Malaysia (USM), 16150, Kubang Kerian, Kelantan, Malaysia
  • 6 National Doping Control Centre, Mahidol University, Rachathawee, Bangkok, 10400, Thailand
  • 7 Institute of Molecular Biosciences, Mahidol University, Salaya Campus, Nakornpathom, 73170, Thailand
Biochem Biophys Rep, 2019 Jul;18:100635.
PMID: 31061897 DOI: 10.1016/j.bbrep.2019.100635

Abstract

This is the first report of QQQ-mass spectrometric identification and quantification of the Hb subunits, alpha, beta, delta and gamma globin peptides, derived from enzymatic-digestion of proteins in the early unknown peaks of the Bio-Rad cation-exchange chromatography of haemoglobin. The objectives were to assess the relationship of the quantity of the free alpha, beta, delta and gamma globin chains with the phenotypic diversity of beta-thalassaemias (β-thal). The results demonstrate that the pools of free globin chains in red blood cells were correlating with the severity of the disease in patients with different phenotypes of β-thal. The mechanism and the regulation of synthesis of free globin chains pool in a normal individual and in patients with different β-thal phenotypes could arise from several mechanisms which will require further investigation. The role of the free globin pool in patients with β-thal for development of novel therapeutic approaches based on these potential targets requires further investigation. Pertinent biomarkers improves the diagnosis of the β-thal, especially in low-income countries where they are most common and allows more effective therapeutic intervention leading to more successful therapeutic outcome.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.